Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.845
+0.030 (1.65%)
At close: Jul 1, 2025, 4:00 PM
1.910
+0.065 (3.52%)
After-hours: Jul 1, 2025, 4:01 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $165.98 million as of July 1, 2025. Its market cap has decreased by -6.61% in one year.
Market Cap
165.98M
Enterprise Value
107.39M
1-Year Change
-6.61%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $165.98M, an increase of 32.56%. That is a compound annual growth rate of 2.34%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.94B |
| Johnson & Johnson | 367.43B |
| AbbVie | 327.84B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 282.92B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.70B |
| AstraZeneca | 215.00B |